The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6 , Pages 1180-1185 , December 2009

Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthma

  • Tari Haahtela, MD, PhD

      Affiliations

    • Skin and Allergy Hospital, Helsinki University Central Hospital, Helsinki, Finland
    • Corresponding Author InformationReprint requests: Tari Haahtela, MD, PhD, Skin and Allergy Hospital, Helsinki University Central Hospital, PO Box 160, 00029 HUS, Finland.
    • ,
  • Klaus Tamminen, MD

      Affiliations

    • Skin and Allergy Hospital, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Tuomo Kava, MD, PhD

      Affiliations

    • Northern-Karelia Central Hospital, Joensuu, Finland
    • ,
  • L. Pekka Malmberg, MD, PhD

      Affiliations

    • Skin and Allergy Hospital, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Paula Rytilä, MD, PhD

      Affiliations

    • Skin and Allergy Hospital, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Kurt Nikander, BA

      Affiliations

    • Respironics, Parsippany, NJ
    • AstraZeneca R&D, Lund, Sweden
    • ,
  • Tore Persson, PhD

      Affiliations

    • AstraZeneca R&D, Lund, Sweden
    • ,
  • Olof Selroos, MD, PhD

      Affiliations

    • Semeco, Ängelholm, Sweden

Received 23 April 2009 ,Revised 16 September 2009 ,Accepted 21 September 2009.

References 

  1. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis. 1987;70:171–179
  2. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339:1194–1200
  3. O'Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW START Investigators Group. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med. 2009;179:19–24
  4. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161:1720–1745
  5. Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, et al. Early intervention in mild persistent asthma: a randomized double-blind study. Lancet. 2003;361:1071–1076
  6. O'Byrne PM, Pedersen S, Busse WW, Tan WC, Chen Y-Z, Ohlsson SV, et al. Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest. 2006;129:1478–1485
  7. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2008. Available at: http://www.ginasthma.com. Accessed February 6, 2009.
  8. Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, et al. Comparison of a β2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991;325:388–392
  9. Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med. 1994;331:700–705
  10. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med. 1994;88:373–381
  11. Selroos O, Pietinalho A, Löfroos A-B, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest. 1995;108:1228–1234
  12. Selroos O, Löfroos A-B, Pietinalho A, Riska H. Asthma control and steroid doses 5 years after early or delayed introduction of inhaled corticosteroids in asthma: a real-life study. Respir Med. 2004;98:254–262
  13. American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children—1999. Am J Respir Crit Care Med. 1999;160:2104–2117
  14. Metso T, Rytilä P, Peterson C, Haahtela T. Granulocyte markers in induced sputum in patients with respiratory disorders and healthy persons obtained by two sputum processing methods. Respir Med. 2001;95:48–55
  15. Taylor DR, Bateman ED, Boulet LD, Boushey HA, Busse WW, Casale TB, et al. A new perspective on concepts of asthma severity and control. Eur Respir J. 2008;32:545–554
  16. In:  Bousquet J,  Khaltaev N editor. Global surveillance, prevention and control of chronic respiratory disease: a comprehensive approach. Geneva: World Health Organization; 2007;
  17. Haahtela T, von Hertzen L, Mäkelä M, Hannuksela M. Allergy Programme Working Group. Finnish Allergy Programme 2008-2018—time to act and change the course. Allergy. 2008;63:634–645
  18. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343:332–336
  19. Adams RJ, Fuhlbrigge A, Finkelstein JA, Lozano P, Livingston JM, Weiss KB, et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics. 2001;107:706–711
  20. Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, et al. A ten-year asthma programme in Finland: major change for the better. Thorax. 2006;61:663–670
  21. Busse WW, Pedersen S, Pauwels RA, Tan WC, Chen Y-Z, Lamm CJ, et al. The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol. 2008;121:1167–1174
  22. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, et al. A low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med. 2001;164:1392–1397
  23. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med. 1999;159:1043–1051
  24. Tukiainen H, Taivainen A, Majander R, Poussa T, Svahn T, Puolijoki H, et al. Comparison of high and low dose of the inhaled steroid, budesonide, as an initial treatment in newly detected asthma. Respir Med. 2000;94:678–683
  25. Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a B2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol. 1992;90:32–42
  26. Panhuysen CI, Vonk JM, Koeter GH, Schouten JP, van Altena R, Bleecker ER, et al. Adult patients may outgrow their asthma: a 25-year follow-up study. Am J Respir Crit Care Med. 1997;155:1267–1272

 Supported by grants from Helsinki University Central Hospital (grant 2303), AstraZeneca, Finland, and AstraZeneca R&D, Lund, Sweden.

 Disclosure of potential conflict of interest: T. Haahtela receives honoraria from ALK-Abelló, AstraZeneca, Meda Oy, MSD, and Orion Pharma; is on the advisory board for MSD and Orion Pharma; and receives grant support from Orion Diagnostics and Stallergenes. K. Tamminen was employed by AstraZeneca Finland until June 2009. T. Kava receives lecture fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, and MSD and receives financial support for attending meetings from Boehringer Ingelheim. P. Rytilä is employed by Orion Pharma. K. Nikander is employed by Philips Respironics. T. Persson is employed by and is a shareholder in AstraZeneca R&D. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(09)01437-7

doi: 10.1016/j.jaci.2009.09.036

The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6 , Pages 1180-1185 , December 2009

Article Tools

* Image Usage & Resolution